Glaukos Shares Outstanding 2014-2024 | GKOS
Glaukos shares outstanding history from 2014 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Glaukos shares outstanding for the quarter ending September 30, 2024 were 0.055B, a 13.07% increase year-over-year.
- Glaukos 2023 shares outstanding were 0.048B, a 2.08% increase from 2022.
- Glaukos 2022 shares outstanding were 0.047B, a 2.2% increase from 2021.
- Glaukos 2021 shares outstanding were 0.046B, a 4.33% increase from 2020.
| Glaukos Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 48 |
| 2022 | 47 |
| 2021 | 46 |
| 2020 | 44 |
| 2019 | 41 |
| 2018 | 35 |
| 2017 | 34 |
| 2016 | 36 |
| 2015 | 17 |
| 2014 | 2 |
| 2013 | 2 |
| Glaukos Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-09-30 | 55 |
| 2024-06-30 | 51 |
| 2024-03-31 | 50 |
| 2023-12-31 | 48 |
| 2023-09-30 | 49 |
| 2023-06-30 | 48 |
| 2023-03-31 | 48 |
| 2022-12-31 | 47 |
| 2022-09-30 | 48 |
| 2022-06-30 | 47 |
| 2022-03-31 | 50 |
| 2021-12-31 | 46 |
| 2021-09-30 | 49 |
| 2021-06-30 | 46 |
| 2021-03-31 | 46 |
| 2020-12-31 | 44 |
| 2020-09-30 | 45 |
| 2020-06-30 | 44 |
| 2020-03-31 | 44 |
| 2019-12-31 | 41 |
| 2019-09-30 | 37 |
| 2019-06-30 | 36 |
| 2019-03-31 | 36 |
| 2018-12-31 | 35 |
| 2018-09-30 | 36 |
| 2018-06-30 | 35 |
| 2018-03-31 | 35 |
| 2017-12-31 | 34 |
| 2017-09-30 | 38 |
| 2017-06-30 | 34 |
| 2017-03-31 | 38 |
| 2016-12-31 | 36 |
| 2016-09-30 | 37 |
| 2016-06-30 | 36 |
| 2016-03-31 | 36 |
| 2015-12-31 | 17 |
| 2015-09-30 | 32 |
| 2015-06-30 | 3 |
| 2015-03-31 | 2 |
| 2014-12-31 | 2 |
| 2014-09-30 | 2 |
| 2014-06-30 | 2 |
| 2014-03-31 | 2 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.499B | $0.315B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.416B | 24.94 |
| Intuitive Surgical (ISRG) | United States | $192.946B | 100.88 |
| Alcon (ALC) | Switzerland | $43.080B | 28.83 |
| Edwards Lifesciences (EW) | United States | $41.404B | 26.29 |
| IQVIA Holdings (IQV) | United States | $36.405B | 20.06 |
| IDEXX Laboratories (IDXX) | United States | $35.383B | 41.67 |
| DexCom (DXCM) | United States | $31.603B | 47.59 |
| Waters (WAT) | United States | $22.979B | 33.98 |
| STERIS (STE) | Ireland | $21.385B | 24.62 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.978B | 0.00 |
| Hologic (HOLX) | United States | $17.581B | 18.99 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.691B | 14.05 |
| Sysmex ADR (SSMXY) | Japan | $13.362B | 41.90 |
| Globus Medical (GMED) | United States | $11.588B | 29.34 |
| Penumbra (PEN) | United States | $9.412B | 92.19 |
| Masimo (MASI) | United States | $9.326B | 45.13 |
| Teleflex (TFX) | United States | $8.737B | 13.94 |
| PROCEPT BioRobotics (PRCT) | United States | $5.035B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.735B | 26.84 |
| Veracyte (VCYT) | United States | $3.384B | 101.54 |
| Inari Medical (NARI) | United States | $3.018B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.803B | 16.18 |
| Nihon Kohden (NHNKY) | Japan | $2.421B | 18.39 |
| TransMedics (TMDX) | United States | $2.398B | 76.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.192B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.121B | 19.07 |
| Integra LifeSciences Holdings (IART) | United States | $1.901B | 9.93 |
| RxSight (RXST) | United States | $1.756B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.248B | 0.00 |
| Artivion (AORT) | United States | $1.244B | 82.44 |
| OPKO Health (OPK) | United States | $1.078B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.875B | 14.87 |
| Paragon 28 (FNA) | United States | $0.856B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.739B | 0.00 |
| IRadimed (IRMD) | United States | $0.680B | 36.74 |
| Mesa Laboratories (MLAB) | United States | $0.668B | 15.75 |
| AxoGen (AXGN) | United States | $0.635B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.634B | 0.00 |
| SiBone (SIBN) | United States | $0.546B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.533B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.527B | 31.04 |
| Pacific Biosciences Of California (PACB) | United States | $0.501B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.453B | 24.53 |
| Delcath Systems (DCTH) | United States | $0.379B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.289B | 0.00 |
| Inogen (INGN) | United States | $0.237B | 0.00 |
| Accuray (ARAY) | United States | $0.211B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.155B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.05 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.092B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.088B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.039B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |